Source LDPath

Source BioScience and Inbiomotion sign an exclusive agreement for MAF Test® in United Kingdom and Ireland

This pioneering test aids oncologists in predicting recurrence and survival rates in breast cancer patients and potential treatment eligibility to bisphosphonates Results showing the clinical utility ...

Understanding the Health Economics of Digital Pathology

It will come as no great surprise that pathology services in the NHS are under enormous pressure. That is perhaps putting it mildly, maybe operational emergency would be more appropriate. Pathology se...

Source LDPath Wins 2023 MedTech Breakthrough Award

Nottingham, UK– May 3, 2023 – Source LDPath, a part of the Source BioScience Group, has been selected as the winner of the “Best Hospital Technology Implementation” award in the 7th annual MedTe...

  • 1
  • 2